Dr. Starr graduated from the University of Southern California Keck School of Medicine in 1978. He works in Diamond Bar, CA and specializes in Family Medicine. Dr. Starr is affiliated with Saint Jude Medical Center.
Name / Title
Company / Classification
Phones & Addresses
Douglas R Starr
ELITE DIGITAL GRAPHICS LLC
Us Patents
Dna Binding Compound-Mediated Molecular Switch System
Moon Young Lim - Redwood City CA, US Cynthia A. Edwards - Morgan Hill CA, US Kirk E. Fry - Palo Alto CA, US Thomas W. Bruice - Carlsbad CA, US Douglas B. Starr - Mountain View CA, US Megan E. Laurance - San Francisco CA, US Yan Kwok - Sunnyvale CA, US Albert W. Tam - San Francisco CA, US
The present invention provides molecular switch system methods and compositions for use in regulatable gene expression. The system includes a nucleic acid construct which has a DNA response sequence for a transcriptional regulatory protein operably linked to a promoter, a compound binding sequence in the vicinity of the DNA response sequence, a transgene under the control of the promoter; and a DNA binding compound. In some cases, the molecular switch system further includes a nucleic acid sequence encoding a transcriptional regulatory protein operably linked to a second promoter. The invention further provides a method for screening compounds for the ability to function in the molecular switch system and thereby regulate gene expression.
Jungsuh Kim - Palo Alto CA, US Douglas Starr - Mountain View CA, US Albert Tam - San Francisco CA, US Megan Laurance - San Francisco CA, US Emil Michelotti - Foster City CA, US Mark Velligan - Montara CA, US Derek Latour - Hayward CA, US Rita Thomas - San Jose CA, US Ana Kongpachith - Union City CA, US Liana Sheppard - Redwood City CA, US Moon Kim - Redwood City CA, US Thomas Bruice - Carlsbad CA, US
International Classification:
C12Q001/70 C07H021/04 C12N009/00 C12N007/00
US Classification:
435/235100, 435/183000, 536/023720, 435/005000
Abstract:
This invention provides nucleic acid sequences, vectors and host cells comprising regulatory regions associated with various promoters including a cyclin D1 promoter, a CD40L promoter, three HBV promoters (core, pre-S1 and HBV-X), a vancomycin-resistant enterococci (VRE) promoter, an androgen receptor promoter, a Her2 promoter, and -lactamase promoter. The invention further provides methods of regulating gene expression comprising the regulatory regions of such promoters.